224 related articles for article (PubMed ID: 15985079)
41. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
42. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
43. DNA cytometry in renal cell carcinoma.
Nenning H; Rassler J; Minh DH
Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
46. DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.
Veloso JD; Solis OG; Barada JH; Fisher HA; Ross JS
Arch Pathol Lab Med; 1992 Feb; 116(2):154-8. PubMed ID: 1733409
[TBL] [Abstract][Full Text] [Related]
47. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
[TBL] [Abstract][Full Text] [Related]
48. In vivo aneuploidization during the expansion of renal adenocarcinoma.
Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
[TBL] [Abstract][Full Text] [Related]
49. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
50. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
[TBL] [Abstract][Full Text] [Related]
51. HER-2/neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma.
Danova M; Giordano M; Torelli F; Franchini G; Cappellano F; Riccardi A; Catanzaro F; Mazzini G
Eur J Histochem; 1992; 36(3):279-88. PubMed ID: 1281010
[TBL] [Abstract][Full Text] [Related]
52. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
53. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
54. Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma.
Madbouly K; Al-Qahtani SM; Ghazwani Y; Al-Shaibani S; Mansi MK
Urology; 2007 Apr; 69(4):670-4. PubMed ID: 17445649
[TBL] [Abstract][Full Text] [Related]
55. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
[TBL] [Abstract][Full Text] [Related]
57. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
58. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
Byun SS; Yeo WG; Lee SE; Lee E
Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
[TBL] [Abstract][Full Text] [Related]
59. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.
Pepe S; Ruggiero A; D'Acquisto M; De Laurentiis M; De Placido S; Sandomenico C; Staibano S; De Rosa G; Lucariello A; D'Armiento M; Bianco AR
Cancer; 2000 Sep; 89(5):1065-75. PubMed ID: 10964337
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]